ABCG2 was initially cloned from multidrug-resistant breast cancer cell lines and demonstrated to confer resistance to chemotherapeutic agents such as mitoxantrone, topotecan, and SN-38 [11,12,13]. Here, ABCG2 is linked to breast carcinoma.